At a glance
ClinicalIndex Comparison RecordN/AUnknown· 160 target
Drug / intervention
Metagenomic shotgun sequencingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Metagenome-wide Association Study of Gut Microbiota in Gastrointestinal Non-Hodgkin's Lymphoma Patients
In Brief
An observational study evaluating Metagenomic shotgun sequencing for Gastrointestinal Lymphoma. Targeting 160 participants across 1 site.
Detailed Summary
This is a observational study on the fecal microbiota in primary/secondary gastrointestinal lymphoma patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal Lymphoma
CountriesChina
Collaborators--
Timeline
N/AUnknownOverdue
2017201820192020202120222023202420252026
Enrollment StartMar 2017
First PostedApr 2019
Primary CompletionSep 2020
Study CompletionDec 2020
TodayJul 2026
First PostedApr 29, 2019
Enrollment StartMar 1, 2017
Primary CompletionSep 30, 2020
Study CompletionDec 1, 2020
TodayJul 1, 2026
Enrollment to primary: 3.6 yearsPosted 7.2 years ago
Interventions
Metagenomic shotgun sequencingother
preforming metagenomic shotgun sequencing on patients' or volunteers' feces specimen